Xencor, Inc.
Heterodimeric antibodies that bind fibroblast activation protein
Last updated:
Abstract:
The present invention relates to novel antigen binding domains and heterodimeric antibodies that bind Fibroblast Activation Protein (FAP).
Status:
Grant
Type:
Utility
Filling date:
4 Apr 2019
Issue date:
20 Apr 2021